Global Financial Private Client’s Integra LifeSciences IART Stock Holding History

Global Financial Private Client’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38	Closed	-$836	–	841
2025 Q1	$836	Hold	38	–	–	﹤0.01%	1114
2024 Q4	$862	Hold	38	–	–	﹤0.01%	808
2024 Q3	$690	Hold	38	–	–	﹤0.01%	768
2024 Q2	$1.11K	Hold	38	–	–	﹤0.01%	613
2024 Q1	$1.32K	Hold	38	–	–	﹤0.01%	620
2023 Q4	$1.66K	Hold	38	–	–	﹤0.01%	597
2023 Q3	$1.44K	Hold	38	–	–	﹤0.01%	597
2023 Q2	$1.56K	Hold	38	–	–	﹤0.01%	589
2023 Q1	$2.16K	Hold	38	–	–	﹤0.01%	568
2022 Q4	$2.13K	Hold	38	–	–	﹤0.01%	557
2022 Q3	$1.67K	Hold	38	–	–	﹤0.01%	542
2022 Q2	$2.09K	Hold	38	–	–	﹤0.01%	518
2022 Q1	$2.53K	Hold	38	–	–	﹤0.01%	514
2021 Q4	$2.55K	Hold	38	–	–	﹤0.01%	509
2021 Q3	$2.64K	Hold	38	–	–	﹤0.01%	449
2021 Q2	$2.63K	Hold	38	–	–	﹤0.01%	457
2021 Q1	$2.59K	Hold	38	–	–	﹤0.01%	410
2020 Q4	$2.47K	Hold	38	–	–	﹤0.01%	406
2020 Q3	$1.8K	Hold	38	–	–	﹤0.01%	412
2020 Q2	$1.85K	Hold	38	–	–	﹤0.01%	450
2020 Q1	$1.62K	Hold	38	–	–	﹤0.01%	462
2019 Q4	$2.21K	Buy	+38	New	+$2.26K	﹤0.01%	471

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Global Financial Private Client's IART Position: Q2 2025 in Review

Global Financial Private Client sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 38 shares — an estimated $836 sold.

Global Financial Private Client first reported a position in IART in Q4 2019 and held it in 22 quarters. The position peaked at $2.64K in Q3 2021. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

Global Financial Private Client reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 38 Integra LifeSciences shares in Q2 2025, an estimated $836.
Global Financial Private Client first reported a position in Integra LifeSciences in Q4 2019 and held it in 22 quarters.
Global Financial Private Client's Integra LifeSciences position peaked at $2.64K in Q3 2021.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.